Literature DB >> 30166957

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Steven C Lin1,2, Adam S Cheifetz1,2.   

Abstract

Complementary and alternative medicine (CAM) includes products or medical practices that encompass herbal and dietary supplements, probiotics, traditional Chinese medicines, and a variety of mind-body techniques. The use of CAM in patients with inflammatory bowel disease (IBD) is increasing as patients seek ways beyond conventional therapy to treat their chronic illnesses. The literature behind CAM therapies and their application, efficacy, and safety is limited when compared to studies of conventional, allopathic therapies. Thus, gastroenterologists are often ill equipped to engage with their patients in informed and meaningful discussions about the role of CAM in IBD. The aims of this article are to provide a comprehensive summary and discussion of various CAM modalities and to appraise the evidence for their use.

Entities:  

Keywords:  Complementary and alternative medicine; Crohn’s disease; acupuncture; cannabis; curcumin; exercise; herbal supplement; probiotics; ulcerative colitis

Year:  2018        PMID: 30166957      PMCID: PMC6111500     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  87 in total

1.  Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.

Authors:  Chun-Hui Bao; Ji-Meng Zhao; Hui-Rong Liu; Yuan Lu; Yi-Fang Zhu; Yin Shi; Zhi-Jun Weng; Hui Feng; Xin Guan; Jing Li; Wei-Feng Chen; Lu-Yi Wu; Xiao-Ming Jin; Chuan-Zi Dou; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Doctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel disease.

Authors:  Réme Mountifield; Jane M Andrews; Antonina Mikocka-Walus; Peter Bampton
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease.

Authors:  Daniel J Stein
Journal:  Gastroenterol Clin North Am       Date:  2017-10-03       Impact factor: 3.806

4.  Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis.

Authors:  H Cramer; M Schäfer; M Schöls; J Köcke; S Elsenbruch; R Lauche; H Engler; G Dobos; J Langhorst
Journal:  Aliment Pharmacol Ther       Date:  2017-04-05       Impact factor: 8.171

5.  Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials.

Authors:  Jun Shen; Zhi-Xiang Zuo; Ai-Ping Mao
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

6.  Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.

Authors:  Dong Il Park; Jae Myung Cha; Hyun Soo Kim; Hong Jun Park; Jung Eun Shin; Sung No Hong; Sung Soo Hong; Wan Jung Kim
Journal:  Complement Ther Med       Date:  2013-12-12       Impact factor: 2.446

7.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

Review 8.  EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.

Authors:  Raquel Cristina Schwanke; Rodrigo Marcon; Allisson Freire Bento; João B Calixto
Journal:  Eur J Pharmacol       Date:  2015-08-29       Impact factor: 4.432

Review 9.  Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jun Ji; Yuan Lu; Huirong Liu; Hui Feng; Fuqing Zhang; Luyi Wu; Yunhua Cui; Huangan Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-24       Impact factor: 2.629

Review 10.  Impact of Omega-3 Fatty Acids on the Gut Microbiota.

Authors:  Lara Costantini; Romina Molinari; Barbara Farinon; Nicolò Merendino
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

View more
  9 in total

1.  Cannabinoid Receptor 2 (CB2) Inverse Agonist SMM-189 Induces Expression of Endogenous CB2 and Protein Kinase A That Differentially Modulates the Immune Response and Suppresses Experimental Colitis.

Authors:  Sonia Kiran; Ahmed Rakib; Bob M Moore; Udai P Singh
Journal:  Pharmaceutics       Date:  2022-04-26       Impact factor: 6.525

Review 2.  Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.

Authors:  Vassiliki Sinopoulou; Morris Gordon; Anthony K Akobeng; Marco Gasparetto; Michael Sammaan; Jessica Vasiliou; Terence M Dovey
Journal:  Cochrane Database Syst Rev       Date:  2021-11-29

Review 3.  Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivo.

Authors:  Hilda Vargas-Robles; Karla Fabiola Castro-Ochoa; Alí Francisco Citalán-Madrid; Michael Schnoor
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

4.  Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients.

Authors:  John Sperger; Kushal S Shah; Minxin Lu; Xian Zhang; Ryan C Ungaro; Erica J Brenner; Manasi Agrawal; Jean-Frederic Colombel; Michael D Kappelman; Michael R Kosorok
Journal:  medRxiv       Date:  2021-01-20

Review 5.  Research Trends of Systematic Review/Meta-Analysis on Acupuncture Therapy: A Bibliometric Analysis.

Authors:  Jinlan Jiang; Jiaxin Zhang; Rongrong Li; Zhengqi Zhao; Xiaolin Ye
Journal:  J Pain Res       Date:  2021-02-26       Impact factor: 3.133

6.  Tripterygium wilfordii Polyglycoside Ameliorated TNBS-Induced Colitis in Rats via Regulating Th17/Treg Balance in Intestinal Mucosa.

Authors:  Cui Zhang; Jingyi Ju; Xiaohan Wu; Jiaolan Yang; Qinglu Yang; Changqin Liu; Liang Chen; Xiaomin Sun
Journal:  J Inflamm Res       Date:  2021-04-01

7.  Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD.

Authors:  John Sperger; Kushal S Shah; Minxin Lu; Xian Zhang; Ryan C Ungaro; Erica J Brenner; Manasi Agrawal; Jean-Frédéric Colombel; Michael D Kappelman; Michael R Kosorok
Journal:  BMJ Open       Date:  2021-11-12       Impact factor: 2.692

8.  Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease.

Authors:  Mario-Livio Jeličić; Daniela Amidžić Klarić; Jelena Kovačić; Donatella Verbanac; Ana Mornar
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-04

9.  Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study.

Authors:  Haya M Almalag; Aseel M Almuhareb; Aya A Alsharafi; Tariq M Alhawassi; Ahmed A Alghamdi; Hussain Alarfaj; Mohammed A Omair; Bedor A Alomari; Maysoon S Alblowi; Hanan H Abouzaid; Abdurhman S Alarfaj
Journal:  Saudi Pharm J       Date:  2021-04-23       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.